BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3493519)

  • 1. Acute otitis media caused by Branhamella catarrhalis: biology and therapy.
    Van Hare GF; Shurin PA; Marchant CD; Cartelli NA; Johnson CE; Fulton D; Carlin S; Kim CH
    Rev Infect Dis; 1987; 9(1):16-27. PubMed ID: 3493519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of acute otitis media caused by Branhamella catarrhalis. Preliminary report.
    Shurin PA; Van Hare GF
    Drugs; 1986; 31 Suppl 3():122-4. PubMed ID: 3488191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapy.
    Lundgren K; Ingvarsson L
    Drugs; 1986; 31 Suppl 3():125-31. PubMed ID: 3488192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nasopharyngeal and middle ear flora in children with acute otitis media].
    Zielnik-Jurkiewicz B; Kolczyńska M
    Otolaryngol Pol; 2005; 59(4):537-42. PubMed ID: 16273858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branhamella catarrhalis in acute otitis media.
    Karma P; Virtanen T; Pukander J; Sipilä M; Luotonen J; Timonen M; Herva E; Grönroos P
    Acta Otolaryngol; 1985; 99(3-4):285-90. PubMed ID: 3874516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon".
    Marchant CD; Carlin SA; Johnson CE; Shurin PA
    J Pediatr; 1992 Jan; 120(1):72-7. PubMed ID: 1731027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribotyping of strains of Moraxella (Branhamella) catarrhalis cultured from the nasopharynx and middle ear of children with otitis media.
    Brygge K; Sørensen CH; Colding H; Ejlertsen T; Højbjerg T; Bruun B
    Acta Otolaryngol; 1998 Jun; 118(3):381-5. PubMed ID: 9655213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media.
    Marchant CD; Shurin PA; Johnson CE; Murdell-Panek D; Feinstein JC; Fulton D; Flexon P; Carlin SA; Van Hare GF
    J Pediatr; 1986 Nov; 109(5):891-6. PubMed ID: 3534203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Otitis media caused by beta-lactamase-producing Branhamella (Neisseria) catarrhalis.
    Lee WS; Fordham T; Alban J
    J Clin Microbiol; 1981 Jan; 13(1):222-3. PubMed ID: 6970205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion.
    Odio CM; Kusmiesz H; Shelton S; Nelson JD
    Pediatrics; 1985 May; 75(5):819-26. PubMed ID: 4039433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent and penicillin V-resistant otitis media. A treatment study with amoxycillin/clavulanate and cefaclor.
    Jacobsson S; Rignér P; von Sydow C; Bondesson G
    Acta Otolaryngol; 1988; 106(3-4):171-7. PubMed ID: 3140574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity of Branhamella catarrhalis.
    Schreiner A
    Acta Otolaryngol Suppl; 1984; 407():40-2. PubMed ID: 6333774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxicillin-clavulanate potassium compared with cefaclor for acute otitis media in infants and children.
    Kaleida PH; Bluestone CD; Rockette HE; Bass LW; Wolfson JH; Breck JM; Ubinger EB; Rohn DD
    Pediatr Infect Dis J; 1987 Mar; 6(3):265-71. PubMed ID: 3554125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae.
    Patel JA; Reisner B; Vizirinia N; Owen M; Chonmaitree T; Howie V
    J Pediatr; 1995 May; 126(5 Pt 1):799-806. PubMed ID: 7752010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of otitis media.
    Thoene DE; Johnson CE
    Pharmacotherapy; 1991; 11(3):212-21. PubMed ID: 1862012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media.
    Marchant CD; Shurin PA; Turcyzk VA; Feinstein JC; Johnson CE; Wasikowski DE; Knapp LJ; Tutihasi MA
    J Pediatr; 1984 Oct; 105(4):633-8. PubMed ID: 6384453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole in the treatment of otitis media caused by ampicillin-resistant strains of Haemophilus influenzae.
    Schwartz RH; Rodriguez WJ; Khan WN; Mann R; Barsanti RG; Ross S
    Rev Infect Dis; 1982; 4(2):514-6. PubMed ID: 6981169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal flora and acute otitis media.
    Long SS; Henretig FM; Teter MJ; McGowan KL
    Infect Immun; 1983 Sep; 41(3):987-91. PubMed ID: 6604029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of Branhamella catarrhalis to oral antibiotics.
    Kallings I
    Drugs; 1986; 31 Suppl 3():17-22. PubMed ID: 3488193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinicobacteriologic study on clavulanic acid/amoxicillin in pediatric acute otitis media].
    Sugita R; Harada S; Deguchi K; Fujimaki Y; Naito M; Komatsu N; Nomura T; Okano K; Tanaka M; Shimizu K; Watanabe H; Kimura S; Yoshida Y; Senba T; Uchida T
    Jpn J Antibiot; 1999 Oct; 52(10):595-612. PubMed ID: 10638456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.